This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $300 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

Dasa Lipovsek, Ph.D.
Vice President, Lead Discovery at Atkis Oncology


Daša Lipovšek is Vice President and Head of Lead Discovery at Aktis Oncology. Prior to joining Aktis, Daša spent 12 years at Bristol Myers Squibb, most recently as Scientific Associate Director in Selection Technologies and Protein Engineering. Her earlier roles include Director of Protein Engineering at Codon Devices; Visiting Scientist in Biological Engineering at MIT; and Associate Director of Biochemistry at Phylos. Throughout her last 25 years in the biopharma industry, Daša has combined structure-based design and in vitro evolution to identify target-binding proteins for use as therapeutic and diagnostic agents, with a particular emphasis on designed single-domain proteins. Daša received a SB in Biology from MIT and a PhD in Chemistry from the University of Cambridge.

Dasa Lipovsek, Ph.D.'s Network

Agenda Sessions

  • Miniproteins for Targeted Radiotherapy